Corporate
Description
  • Value proposition

    Pioneering Diagnostics

    Pioneering Diagnostics

    A world leader in the field of in vitro diagnostics for more than 60 years, bioMérieux is present in 45 countries and serves more than 160 countries with the support of a large network of distributors.

    In 2020, revenues reached €3.1 billion, with over 90% of sales outside of France.

    bioMérieux provides diagnostic solutions (systems, reagents, software, services) which determine the source of disease and contamination to improve patient health and ensure consumer safety.

    Its products are mainly used for diagnosing infectious diseases. They are also used for detecting microorganisms in agri-food, pharmaceutical and cosmetic products.

    bioMérieux is listed on the Euronext Paris stock market.

    Symbol: BIM – ISIN Code: FR0013280286
    Reuters: BIOX.PA/Bloomberg: BIM.FP


    in vitro diagnostics, infectious diseases, reagents, automated instruments, medical analysis, cosmetics, pharmaceutical, industries, healthcare associated infections, molecular biology, microbiology, immunoassays, antimicrobial stewardship, rapid diagnostics, food safety, veterinary diagnostics, blood bank, and sepsis

  • Original language

    Pioneering Diagnostics

    Pioneering Diagnostics

    A world leader in the field of in vitro diagnostics for more than 60 years, bioMérieux is present in 45 countries and serves more than 160 countries with the support of a large network of distributors.

    In 2020, revenues reached €3.1 billion, with over 90% of sales outside of France.

    bioMérieux provides diagnostic solutions (systems, reagents, software, services) which determine the source of disease and contamination to improve patient health and ensure consumer safety.

    Its products are mainly used for diagnosing infectious diseases. They are also used for detecting microorganisms in agri-food, pharmaceutical and cosmetic products.

    bioMérieux is listed on the Euronext Paris stock market.

    Symbol: BIM – ISIN Code: FR0013280286
    Reuters: BIOX.PA/Bloomberg: BIM.FP

Entity interactions BETA
Entity TypeTweets Articles
POC Media POC Media
Other

27 Nov 2024


Point S Point S
transporttech
Other

10 Dec 2024


mind Health mind Health
healthtech, Online Audio and Video Media
Other

22 Nov 2024


PHAXIAM Therapeutics PHAXIAM Therapeutics
biotech, deeptech, Biotechnology Research
Other

22 Nov 2024


Navy Yard Philadelphia Navy Yard Philadelphia
proptech, Non-profit Organizations
Other

26 Nov 2024


L'Essor Affiches Loire L'Essor Affiches Loire
Newspaper Publishing
Other

26 Nov 2024


ALL - Accor Live Limitless ALL - Accor Live Limitless
entertainment, Travel Arrangements
Other

17 Nov 2024


Supernova Invest Supernova Invest
Venture Capital and Private Equity Principals
Other

16 Nov 2024


SERFIM T.I.C. SERFIM T.I.C.
it services, IT Services and IT Consulting
Other

9 Nov 2024


Laboratoire Microsept Laboratoire Microsept
deeptech
Other

16 Oct 2024


Radars
Loading...